共 176 条
[11]
Ofir D(2004)Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Eur Respir J 23 832-427
[12]
Jensen D(2006)The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease Respiration 73 420-49
[13]
Rossi A(2015)Faster reduction in hyperinflation and improvement in lung ventilation inhomogeneity promoted by aclidinium compared to glycopyrronium in severe stable COPD patients. A randomized crossover study Pulm Pharmacol Ther 35 42-1923
[14]
Aisanov Z(2015)Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial Int J Chron Obstr Pulm Dis 10 1917-587
[15]
Avdeev S(2011)Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD Respir Med 105 580-3271
[16]
Di Maria G(2017)Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease Drug Des Dev Ther 11 3257-169
[17]
Donner CF(2018)In vitro characterization of the eFlow closed system nebulizer with glycopyrrolate inhalation solution J Aerosol Med Pulm Drug Deliv 31 162-250
[18]
Izquierdo JL(2017)Efficacy and safety of glycopyrrolate/eFlow((R)) CS (nebulized glycopyrrolate) in moderate-to-very-severe COPD: Results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 3 and 4 randomized controlled trials Respir Med 132 238-260
[19]
Watz H(2017)Long-term safety of glycopyrrolate/eFlow((R)) CS in moderate-to-very-severe COPD: results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 5 randomized study Respir Med 132 251-301
[20]
Waschki B(2020)In vitro effect of different airflow rates on the aerosol properties of nebulized glycopyrrolate in the eFlow(R) closed system and tiotropium delivered in the HandiHaler(R) Pulm Ther 6 289-1331